Register Today to Hear New Data on Over 40
Antibody Alternative and Protein Engineering Projects
Do you have new research you would like to share? Then, submit a poster. The poster committee is now taking submissions for this event until September 4, 2009. All poster submission but be submittted online.
Engineering the Next Generation of Protein Therapeutics
This one-of-a-kind meeting features over 40 exclusive case studies giving you insights into novel strategies for accelerating antibody-like and non-antibody scaffolds to the clinic and emerging protein engineering and design strategies to improve properties of current platforms. Take advantage of this invaluable opportunity to make new contacts to help your company accelerate the next generation of products to the clinic - and move your career in the right direction. Register early to maximize your savings - best rate ends June 26th.
|
Beyond Antibodies IBC's 4th Beyond Antibodies conference provides you with the latest preclinical and clinical results of novel scaffolds from all the key players/companies in this field. By attending, you will hear about the challenges, lessons learned and successes achieved to help you benchmark your own efforts against industry leaders. Accelerate your own projects by applying lessons you will learn from multiple scaffolds progressing to the clinic:
|
Protein Engineering & Design IBC's Protein Engineering & Design conference explores the cutting-edge of practical protein engineering....where the field is heading and novel strategies being applied today....and provides you access to key thought leaders and strategies to help you improve protein properties and functionality. Improve the functionality and biophysical properties of your molecules by applying novel approaches to engineering:
|
Featured Presentations
An FDA Perspective
Marjorie Shapiro, Ph.D., CDER/FDA
Two-in-One Antibody
Germaine Fuh, Ph.D., Genentech
Keynote Presentation
Recombinant Immunotoxins: Building on Success in Hairy Cell Leukemia
Ira Pastan, M.D., Chief, Laboratory of Molecular Biology, National Cancer Institute, NIH
Copyright IBC Life Sciences, a part of Informa Life Sciences Group